ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Alzheimer's psychosis: 52-Week safety trial launches
Symptom relief ENROLLING_BY_INVITATIONThis study tests the long-term safety of an experimental drug, ACP-204, for people with Alzheimer's disease who also experience psychosis (hallucinations or delusions). It is an open-label extension, meaning everyone gets the drug, and follows 752 adults aged 55-95 for 52 weeks. …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
Breakfast or not? study tests new pill for brain disorders
Knowledge-focused OngoingThis study looks at how taking a new extended-release tablet (LY03020) with or without food changes the way the body absorbs the drug. The medicine is being developed for schizophrenia and psychosis in Alzheimer's disease. Sixteen healthy adults will take the drug twice—once afte…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 08:19 UTC